
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.790 | 1.900 | 0.110 |
Shares | 98.100 | 98.100 | 0.000 |
Preferred | 0.100 | 0.100 | 0.000 |
Other | 0.020 | 0.020 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.641 | 16.085 |
Price to Book | 3.602 | 2.679 |
Price to Sales | 2.537 | 2.072 |
Price to Cash Flow | 16.927 | 10.333 |
Dividend Yield | 2.536 | 2.800 |
5 Years Earnings Growth | 19.656 | 11.965 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 34.540 | 12.796 |
Financial Services | 24.300 | 20.182 |
Industrials | 21.700 | 13.954 |
Consumer Defensive | 8.660 | 8.137 |
Basic Materials | 7.700 | 9.047 |
Technology | 1.800 | 20.121 |
Consumer Cyclical | 1.300 | 12.350 |
Number of long holdings: 60
Number of short holdings: 18
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.33 | 92.92 | -0.01% | |
ABB | CH0012221716 | 6.94 | 44.69 | -1.54% | |
Roche Holding Participation | CH0012032048 | 6.61 | 271.40 | -0.22% | |
Nestle | CH0038863350 | 6.26 | 88.16 | +0.94% | |
UBS Group | CH0244767585 | 6.08 | 25.41 | -0.16% | |
Zurich Insurance Group | CH0011075394 | 5.17 | 593.60 | +0.37% | |
Alcon | CH0432492467 | 4.51 | 79.64 | -1.29% | |
Lonza Group | CH0013841017 | 3.61 | 592.60 | -0.90% | |
Sika | CH0418792922 | 3.33 | 206.80 | -0.67% | |
Swiss Life Holding | CH0014852781 | 3.24 | 846.00 | +0.52% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBAM Swiss Eq UD CHF | 1.73B | 9.15 | -5.80 | - | ||
UBAM Swiss Eq RC CHF | 1.73B | 7.17 | -1.69 | 5.55 | ||
UBAM Swiss Eq AHC CHF | 1.73B | 8.51 | -6.20 | - | ||
UBAM Swiss Eq IHC CHF | 1.73B | 8.95 | -5.83 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review